Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels Predict Future Cardiovascular Event Risks in Hemodialyzed Black African Patients

CONTEXT AND OBJECTIVE: Cardiovascular diseases are the leading cause of mortality in patients. In this context, proprotein convertase subtilisin/kexin type 9 (PCSK9) appears to be the new biomarker identified as interfering in lipid homeostasis. This study aimed to investigate the association betwee...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Rambam Maimonides Med J
Autors principals: Kajingulu, François-Pantaléon Musungayi, Lepira, François Bompeka, Nkodila, Aliocha Natuhoyila, Makulo, Jean-Robert Rissassy, Mokoli, Vieux Momeme, Ekulu, Pepe Mfutu, Bukabau, Justine Busanga, Nlandu, Yannick Mayamba, Longo, Augustin Luzayadio, Nseka, Nazaire Mangani, Sumaili, Ernest Kiswaya
Format: Artigo
Idioma:Inglês
Publicat: Rambam Health Care Campus 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284989/
https://ncbi.nlm.nih.gov/pubmed/34270402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5041/RMMJ.10443
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars